Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P, Pulsipher MA, Bethge W, Sahebi F, Bruno B, Maris MB, Yeager A, Petersen FB, Vindeløv L, McSweeney PA, Hübel K, Mielcarek M, Georges GE, Niederwieser D, Blume KG, Maloney DG, Storb R.

JAMA. 2011 Nov 2;306(17):1874-83. doi: 10.1001/jama.2011.1558.

3.

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.

Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, Van Biezen A, Michallet M, Niederwieser D; Chronic Leukemia Working Party of the EBMT.

Leukemia. 2003 May;17(5):841-8. Review.

PMID:
12750695
4.

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.

Baron F, Sandmaier BM.

Leukemia. 2006 Oct;20(10):1690-700. Epub 2006 Jul 27. Review.

5.

Nonmyeloablative allogeneic hematopoietic cell transplantation.

Storb R, Sandmaier BM.

Haematologica. 2016 May;101(5):521-30. doi: 10.3324/haematol.2015.132860. Review.

6.

[Non-myeloablative therapy and allogeneic hematopoietic stem cell transplantation in hematologic malignancies].

Hansz J.

Pol Arch Med Wewn. 2001;105 Suppl:173-5. Review. Polish. No abstract available.

PMID:
12412244
7.

Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.

Strober S, Spitzer TR, Lowsky R, Sykes M.

Semin Immunol. 2011 Aug;23(4):273-81. doi: 10.1016/j.smim.2011.05.001. Epub 2011 Jun 25. Review.

8.

Quality of life after allogeneic hematopoietic cell transplantation.

Pidala J, Anasetti C, Jim H.

Blood. 2009 Jul 2;114(1):7-19. doi: 10.1182/blood-2008-10-182592. Epub 2009 Mar 31. Review.

9.
10.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS.

Biol Blood Marrow Transplant. 2011 Feb;17(2):157-66. doi: 10.1016/j.bbmt.2010.07.009. Epub 2010 Jul 24. Review.

11.

Biologic vs physiologic age in the transplant candidate.

Artz AS.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):99-105. Review.

PMID:
27913468
12.

Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.

Elsawy M, Sorror ML.

Bone Marrow Transplant. 2016 Oct;51(10):1283-1300. doi: 10.1038/bmt.2016.141. Epub 2016 Jun 6. Review.

PMID:
27272454
13.

Chronic kidney disease after hematopoietic cell transplantation: a systematic review.

Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD.

Am J Transplant. 2008 Nov;8(11):2378-90. doi: 10.1111/j.1600-6143.2008.02408.x. Review. Erratum in: Am J Transplant. 2009 Apr;9(4):865. Kambay, M [corrected to Kanbay, M].

14.

Mouse models of graft-versus-host disease.

Reddy P, Ferrara JLM.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2009 Feb 28.

15.

Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training.

Scott JM, Armenian S, Giralt S, Moslehi J, Wang T, Jones LW.

Crit Rev Oncol Hematol. 2016 Feb;98:222-34. doi: 10.1016/j.critrevonc.2015.11.007. Epub 2015 Nov 17. Review.

16.

Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients.

Deeg HJ.

Bone Marrow Transplant. 2015 Sep;50(9):1145-9. doi: 10.1038/bmt.2015.130. Epub 2015 Jun 8. Review.

PMID:
26052908
17.

Making inroads to the cure: Barriers to clinical trial enrollment in hematopoietic cell transplantation.

Byrne M, Danielson N, Harris A, Savani BN.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12948. Epub 2017 Apr 17. Review.

PMID:
28256053

Supplemental Content

Support Center